About Interim LSU Public Hospital
Clinical Trials at Interim LSU Public Hospital
During the past decade, Interim LSU Public Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 5 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Interim LSU Public Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 3 trials, followed by "Alliance for Clinical Trials in Oncology" with 2 trials
sponsored, "SWOG Cancer Research Network" with 2 trials sponsored, "AIDS Malignancy Consortium" with 1 trials sponsored and "NSABP Foundation Inc"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Interim LSU Public Hospital"
#1 collaborator was "National Cancer Institute (NCI)" with 6 trials as a collaborator, "The Emmes Company, LLC" with 1 trials as a collaborator and "University of Arkansas" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Interim LSU Public Hospital
According to Clinical.Site data, the most researched conditions in "Interim LSU Public Hospital" are
"Breast Cancer" (1 trials), "Breast Carcinoma" (1 trials), "Colorectal Cancer" (1 trials), "Extensive Stage Small Cell Lung Cancer" (1 trials) and "HIV Infection" (1 trials). Many other conditions were trialed in "Interim LSU Public Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Interim LSU Public Hospital
Most popular intervention types in "Interim LSU Public Hospital" are "Drug" (8 trials), "Other" (6 trials) and "Biological" (3 trials). Other intervention types were less common.
The name of intervention was led by "Paclitaxel" (3 trials), "placebo" (3 trials), "Bevacizumab" (2 trials), "Carboplatin" (2 trials) and "celecoxib" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Interim LSU Public Hospital
The vast majority of trials in "Interim LSU Public Hospital" are
8 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Interim LSU Public Hospital
Currently, there are NaN active trials in "Interim LSU Public Hospital".
undefined are not yet recruiting,
undefined are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Interim LSU Public Hospital,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Interim LSU Public Hospital, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".